TrialPloS one2025

Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast cancer chemotherapy on quality of life or exercise behaviour.

Claire M Douglas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.